Ganesh V. Kaundinya

2017

In 2017, Ganesh V. Kaundinya earned a total compensation of $1.5M as Chief Operating Officer and Chief Scientific Officer at Momenta Pharmaceuticals, a 9% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$196,800
Option Awards$433,073
Salary$448,517
Stock Awards$425,068
Other$13,481
Total$1,516,939

Kaundinya received $448.5K in salary, accounting for 30% of the total pay in 2017.

Kaundinya also received $196.8K in non-equity incentive plan, $433.1K in option awards, $425.1K in stock awards and $13.5K in other compensation.

Rankings

In 2017, Ganesh V. Kaundinya's compensation ranked 6,929th out of 14,666 executives tracked by ExecPay. In other words, Kaundinya earned more than 52.8% of executives.

ClassificationRankingPercentile
All
6,929
out of 14,666
53rd
Division
Manufacturing
2,566
out of 5,768
56th
Major group
Chemicals And Allied Products
829
out of 2,074
60th
Industry group
Drugs
643
out of 1,730
63rd
Industry
Biological Products, Except Diagnostic Substances
118
out of 316
63rd
Source: SEC filing on April 27, 2018.

Kaundinya's colleagues

We found five more compensation records of executives who worked with Ganesh V. Kaundinya at Momenta Pharmaceuticals in 2017.

2017

Craig Wheeler

Momenta Pharmaceuticals

Chief Executive Officer

2017

Santiago Arroyo

Momenta Pharmaceuticals

Chief Medical Officer

2017

Matthew Ottmer

Momenta Pharmaceuticals

Chief Operating Officer

2017

Bruce Leicher

Momenta Pharmaceuticals

General Counsel

2017

Scott Storer

Momenta Pharmaceuticals

Chief Financial Officer

You may also like